Sanuwave Health Return on Tangible Equity 2010-2025 | SNWV

Current and historical return on tangible equity values for Sanuwave Health (SNWV) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
Sanuwave Health Return On Tangible Equity Historical Data
Date TTM Net Income Tangible Equity Return on Tangible Equity
2025-03-31 $-0.03B $-0.03B 75.86%
2024-12-31 $-0.03B $-0.02B 62.44%
2024-09-30 $0.00B $-0.07B 1.69%
2024-06-30 $0.00B $-0.05B 6.58%
2024-03-31 $-0.02B $-0.06B 27.17%
2023-12-31 $-0.03B $-0.06B 38.24%
2023-09-30 $-0.05B $-0.08B 74.07%
2023-06-30 $-0.03B $-0.07B 45.57%
2023-03-31 $-0.02B $-0.07B 34.12%
2022-12-31 $-0.01B $-0.05B 20.51%
2022-09-30 $-0.01B $-0.05B 26.80%
2022-06-30 $-0.02B $-0.05B 33.33%
2022-03-31 $-0.03B $-0.05B 58.70%
2021-12-31 $-0.03B $-0.05B 65.85%
2021-09-30 $-0.03B $-0.04B 85.71%
2021-06-30 $-0.04B $-0.04B 121.88%
2021-03-31 $-0.03B $-0.03B 130.77%
2020-12-31 $-0.03B $-0.03B 147.13%
2020-09-30 $-0.02B $-0.03B 133.33%
2020-06-30 $-0.01B $-0.02B 101.96%
2020-03-31 $-0.01B $-0.01B 92.31%
2019-12-31 $-0.01B $-0.01B 80.00%
2019-09-30 $-0.01B $-0.01B 66.67%
2019-06-30 $-0.01B $-0.02B 53.33%
2019-03-31 $-0.01B $-0.02B 54.24%
2018-12-31 $-0.01B $-0.02B 84.21%
2018-09-30 $-0.01B $-0.01B 100.00%
2018-06-30 $-0.01B $-0.02B 108.33%
2018-03-31 $-0.01B $-0.01B 107.32%
2017-12-31 $-0.01B $-0.01B 58.82%
2017-09-30 $0.00B $-0.01B 51.61%
2017-06-30 $0.00B $-0.01B 57.14%
2017-03-31 $0.00B $-0.01B 61.54%
2016-12-31 $-0.01B $-0.01B 96.00%
2016-09-30 $-0.01B $-0.01B 83.33%
2016-06-30 $-0.01B $-0.01B 83.33%
2016-03-31 $-0.01B $-0.01B 104.35%
2015-12-31 $-0.01B $-0.01B 100.00%
2015-09-30 $0.00B $-0.01B 100.00%
2015-06-30 $0.00B $-0.01B 145.45%
2015-03-31 $0.00B $0.00B 266.67%
2014-12-31 $-0.01B $0.00B 1200.00%
2014-09-30 $-0.01B $0.00B 400.00%
2014-06-30 $-0.01B $0.00B 307.69%
2014-03-31 $-0.01B $0.00B 138.46%
2013-12-31 $-0.01B $-0.01B 112.82%
2013-09-30 $-0.01B $-0.01B 120.00%
2013-06-30 $-0.01B $-0.01B 90.00%
2013-03-31 $-0.01B $-0.01B 109.09%
2012-12-31 $-0.01B $-0.01B 92.31%
2012-09-30 $-0.01B $-0.01B 114.29%
2012-06-30 $-0.01B $-0.01B 186.67%
2012-03-31 $-0.01B $-0.01B 444.44%
2011-12-31 $-0.01B $0.00B 285.71%
2011-09-30 $-0.02B $0.00B 260.87%
2011-06-30 $-0.02B $0.00B 172.97%
2011-03-31 $-0.02B $-0.01B 120.00%
2010-12-31 $-0.02B $-0.01B 128.00%
2010-09-30 $-0.01B $-0.02B 104.35%
2010-06-30 $-0.01B $-0.01B 129.73%
2010-03-31 $-0.01B $-0.01B 133.33%
2009-12-31 $-0.01B $-0.01B 200.00%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.256B $0.033B
SANUWAVE Health, Inc. is engaged in the development and commercialization of non-invasive, biological response-activating devices for the repair and regeneration of tissue, musculoskeletal and vascular structures. The Company's product candidates include its proprietary PACE technology applicable in wound healing, orthopedic/spine, plastic/cosmetic and cardiac conditions; and dermaPACE for treatment of the skin and subcutaneous soft tissue. The Company's products help in activating biologic signaling and angiogenic responses, including new vascularization and microcirculatory improvement, helping to restore the body's normal healing processes and regeneration. SANUWAVE Health, Inc. is based in Alpharetta, USA.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $233.799B 28.11
Boston Scientific (BSX) United States $157.605B 39.46
Stryker (SYK) United States $150.214B 31.41
EssilorLuxottica (ESLOY) France $126.765B 0.00
Medtronic (MDT) Ireland $110.324B 15.64
Lonza Group Ag (LZAGY) Switzerland $50.804B 0.00
Haleon (HLN) United Kingdom $46.676B 26.62
ResMed (RMD) United States $37.413B 28.10
GE HealthCare Technologies (GEHC) United States $34.057B 16.17
Agilent Technologies (A) United States $33.852B 22.07
Terumo (TRUMY) Japan $27.835B 36.15
Koninklijke Philips (PHG) Netherlands $23.245B 16.31
Insulet (PODD) United States $22.033B 86.49
Zimmer Biomet Holdings (ZBH) United States $18.095B 11.62
Baxter (BAX) United States $15.595B 11.64
Smith & Nephew SNATS (SNN) United Kingdom $13.236B 0.00
Demant (WILYY) Denmark $9.110B 0.00
Sunny Optical Technology (SNPTF) China $8.561B 0.00
Bio-Rad Laboratories (BIO) United States $6.639B 23.10
Lantheus Holdings (LNTH) United States $5.638B 14.22
Prestige Consumer Healthcare (PBH) United States $3.998B 17.86
Perrigo (PRGO) Ireland $3.649B 9.25
Haemonetics (HAE) United States $3.545B 16.15
Shandong Weigao Medical Polymer (SHWGF) China $3.459B 0.00
Envista Holdings (NVST) United States $3.334B 27.70
ICU Medical (ICUI) United States $3.244B 23.92
QuidelOrtho (QDEL) United States $1.952B 13.43
LeMaitre Vascular (LMAT) United States $1.866B 41.70
AtriCure (ATRC) United States $1.598B 0.00
AdaptHealth (AHCO) United States $1.289B 13.08
Acuren (TIC) United States $1.271B 0.00
Green Thumb Industries (GTBIF) United States $1.111B 25.00
Phibro Animal Health (PAHC) United States $1.040B 13.30
Neogen (NEOG) United States $1.027B 13.14
BioLife Solutions (BLFS) United States $1.021B 0.00
Kestra Medical Technologies (KMTS) United States $0.907B 0.00
InMode (INMD) Israel $0.897B 9.04
Owens & Minor (OMI) United States $0.685B 5.69
CeriBell (CBLL) United States $0.683B 0.00
Maravai LifeSciences Holdings (MRVI) United States $0.629B 0.00
Evolus (EOLS) United States $0.589B 0.00
Curaleaf Holdings (CURLF) Canada $0.531B 0.00
Capricor Therapeutics (CAPR) United States $0.509B 0.00
Valneva SE (VALN) France $0.494B 0.00
Surmodics (SRDX) United States $0.412B 0.00
Tilray Brands (TLRY) Canada $0.403B 0.00
VAREX IMAGING (VREX) United States $0.354B 13.00
Quanterix (QTRX) United States $0.332B 0.00
SNDL (SNDL) Canada $0.323B 0.00
SEMPERIT AG HLD (SEIGY) Austria $0.301B 0.00
Viemed Healthcare (VMD) United States $0.274B 23.07
Cerus (CERS) United States $0.271B 0.00
ZimVie (ZIMV) United States $0.258B 11.72
Sanara MedTech (SMTI) United States $0.253B 0.00
Brainsway (BWAY) Israel $0.250B 66.10
Cresco Labs (CRLBF) United States $0.246B 0.00
Aurora Cannabis (ACB) Canada $0.233B 69.17
Biote (BTMD) United States $0.230B 6.46
OraSure Technologies (OSUR) United States $0.225B 0.00
Canopy Growth (CGC) Canada $0.224B 0.00
TriSalus Life Sciences (TLSI) United States $0.201B 0.00
Utah Medical Products (UTMD) United States $0.188B 15.29
Omeros (OMER) United States $0.188B 0.00
High Tide (HITI) Canada $0.184B 0.00
Organigram Global (OGI) Canada $0.181B 0.00
Verano Holdings (VRNOF) United States $0.177B 0.00
Exagen (XGN) United States $0.149B 0.00
Vireo Growth (VREOF) United States $0.144B 0.00
FitLife Brands (FTLF) United States $0.120B 14.81
Jin Medical (ZJYL) China $0.102B 0.00
Fonar (FONR) United States $0.092B 11.90
Oramed Pharmaceuticals (ORMP) United States $0.088B 0.00
Veru (VERU) United States $0.085B 0.00
Apyx Medical (APYX) United States $0.082B 0.00
Quipt Home Medical (QIPT) United States $0.078B 0.00
Zynex (ZYXI) United States $0.077B 0.00
Cytosorbents (CTSO) United States $0.077B 0.00
TerrAscend (TSNDF) Canada $0.077B 0.00
MacroGenics (MGNX) United States $0.075B 0.00
InterCure (INCR) Israel $0.068B 0.00
Agape ATP (ATPC) $0.066B 0.00
ImmuCell (ICCC) United States $0.061B 0.00
Jushi Holdings (JUSHF) United States $0.057B 0.00
Nephros (NEPH) United States $0.041B 55.14
United-Guardian (UG) United States $0.037B 12.94
Modular Medical (MODD) United States $0.037B 0.00
Rockwell Medical (RMTI) United States $0.027B 0.00
Safety Shot (SHOT) United States $0.023B 0.00
Allurion Technologies (ALUR) United States $0.018B 0.00
INLIF (INLF) $0.016B 0.00
Meihua Medical Technologies (MHUA) China $0.014B 0.00
Cellectar Biosciences (CLRB) United States $0.014B 0.00
Flora Growth (FLGC) United States $0.014B 0.00
Trinity Biotech (TRIB) Ireland $0.012B 0.00
Senestech (SNES) United States $0.010B 0.00
Innovative Eyewear (LUCY) United States $0.006B 0.00
IM Cannabis (IMCC) Canada $0.006B 0.00
GlucoTrack (GCTK) United States $0.003B 0.00
Akanda (AKAN) Canada $0.002B 0.00
Sharps Technology (STSS) United States $0.000B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00